The Density of CD10 Corresponds to Commitment and Progression in the Human B Lymphoid Lineage by Ichii, Michiko et al.
The Density of CD10 Corresponds to Commitment and
Progression in the Human B Lymphoid Lineage
Michiko Ichii
1, Kenji Oritani
2, Takafumi Yokota
2, Qingzhao Zhang
1, Karla P. Garrett
1, Yuzuru Kanakura
2,
Paul W. Kincade
1*
1Immunobiology and Cancer Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, United States of America, 2Department of Hematology and
Oncology, Osaka University Graduate School of Medicine, Osaka, Japan
Abstract
Background: Requirements for human B lymphopoiesis are still poorly understood, and that has hampered investigation of
differentiation events. For example, there are few cell surface antigens that can be used as milestones of lineage
progression. The CD10 ectoenzyme is one such marker and has been used to define CLP, but we found substantial tissue
specific variations in CD10 levels, and there was no information about how that corresponded to differentiation options.
Methodology/Principal Findings: The aim of the present study was to use recently developed culture methods to assess the
nature and differentiation potential of progenitors sorted according to CD10 density from umbilical cord blood (CB), adult
bone marrow (BM) or G-CSF mobilized peripheral blood (PB). Many CD34
+ cells in BM express high levels of CD10, while low or
low/negative CD10 densities were found on CD34
+ cells in CB or G-CSF mobilized PB, respectively. The relative abundance of
CD10
Lo versus CD10
Hi cells only accounts for some CB versus BM differences. Almost all of the CD34
+ CD10
Hi cells expressed
CD19 and lymphocyte transcription factors and corresponded to loss of myeloid potential. A high degree of immunoglobulin
DH-JH gene rearrangements was characteristic only of the CD10
Hi subset. In contrast, the CD34
+ CD10
Lo progenitors efficiently
produced plasmacytoid and conventional dendritic cells as well as myeloid cells. These findings suggest a positive correlation
betweenCD10 densityanddegree of differentiation. Although freshly isolatedCD34
+ CD10
Hi cells were incycle,those from CB
or BM expanded poorly in culture, suggesting regulators of populations remain to be discovered.
Conclusions/Significance: Steps in human B lymphopoiesis have not been sufficiently studied, and we now show that
increased CD10 expression corresponds to differentiation potential and stage. CD34
+ CD10
Hi progenitors are obviously in
the B lineage but may have progressed beyond the point where they can be expanded in culture.
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Introduction
Common lymphoid progenitors (CLP) were originally defined
in mice as lineage marker negative, IL-7Ra
+, Sca-1
+, c-Kit
Lo cells
that appeared to be largely restricted to the production of B, T and
NK cells [1]. The original CLP subset has been subdivided and re-
defined in multiple ways, and the potential of these cells to
produce small numbers of non-lymphoid cells is still debated [2–
7]. Moreover, a picture is emerging of asynchronous expression of
lymphoid genes and markers, with gradual restriction of
differentiation options [8,9].
Although the CD10 ectoenzyme is not expressed on murine
progenitors, it has been used in the definition of human CLP [10–
12]. The current consensus is that CD10 is expressed on early, pro-,
and pre- B cells while levels are down-regulated after development
to mature B cells. Other markers exploited in studies of human but
not murine CLP include CD45RA, CD7 and CD38 [13–15]. In
addition, multiple differentiation pathways can result in production
of similar cells such as T and B lymphocytes [16–18]. There are
additional reasons comparisons between murine and human
lymphoid progenitors are difficult. For example, IL-7 is not essential
for human B lymphopoiesis, and no factors have been discovered
that support efficient B lymphoid lineage progression in culture
[19]. For these and other reasons, results obtained in studies
conducted withbone marrowfrom young adult mice are not readily
comparable to those using human umbilical cord blood (CB), adult
bone marrow (BM) or G-CSF mobilized peripheral blood (G-PB).
Allogeneic hematopoietic stem cell transplantation is a curative
treatment for patients with hematopoietic malignancies and
marrow failure syndrome [20–22]. However, the composition of
the donor inoculum has a substantial influence on transplantation
related mortality, occurrence of graft-versus-host disease and
relapse of diseases. For example, high numbers of infused CD34
+
CD19
+ B progenitors were associated with lower incidences of
acute GVHD and transplant related mortality [23]. More
information about stages of B lymphopoiesis and how they vary
in different stem cell sources could improve clinical outcomes.
We have now found that human CD34
+ cells from CB, BM and
G-PB express a wide range of CD10 densities. Increasing levels
of CD10 corresponded to expression of lymphoid related
PLoS ONE | www.plosone.org 1 September 2010 | Volume 5 | Issue 9 | e12954transcription factors and markers, as well as loss of proliferative
potential in two recently developed culture systems. Moreover,
myeloid differentiation potential was not completely lost until
CD10 levels were very high. Complete restriction to a B lineage
lymphoid fate may be a very late event in human lymphopoiesis.
Results and Discussion
Hematopoietic progenitors in different sites vary with
respect to CD10 density and composition
We developed a new co-culture system where CD34
+
hematopoietic cells are sorted and placed on monolayers of
human mesenchymal stem cells along with stem cell factor (SCF)
and Flt3 ligand (see Materials & Methods). Under these
conditions, CD10
+ CD19
+ lymphocytes emerged within 2–3
weeks. As noted in previous studies, the source of the progenitors
was an important variable, and the efficiency was reproducibly
higher in cultures initiated with CB (Figure S1) [13,24,25].
Differences in the composition of CD34
+ cell suspensions might
account for this, because it has been found that CD10
+ progenitors
from CB and BM are functionally equivalent [14,26]. That is, we
considered that CB could be enriched with respect to CD10
+ CLP.
To our surprise, BM contained more CD10
+ cells, and the average
density of this marker was much higher (Figure 1).
CD34
+ cells were then enriched in samples representing three
sources and flow cytometry was used to discern expression of other
markers associated with early events in human hematopoiesis
(Figure 2). Down-regulation of CD117/c-Kit occurs with progres-
sion from the stem/multipotential progenitor stage, and this
receptor for SCF was entirely lacking in the CD10
Hi subset of
CD34
+ cells. Similarly, the CD135 receptor for Flt3 ligand, the
CD90/Thy-1 antigen and the CD123 receptor for interleukin 3
were low on CD10
Hi cells. Only small numbers of CD10
Lo cells in
BM displayed the CD33 myeloid marker. The deficiency of stem
and early progenitor markers was offset by expression of CD9,
CD24 and CD19 lymphoid associated antigens on CD10
Hi
CD34
+ cells. Although the incidence of CD10
+ cells in G-PB
was low, staining patterns with the other markers were very similar
to CB and BM (data not shown). In fact, when CD34
+ cells were
resolved according to CD10 density, patterns of all other markers
were remarkably similar, regardless of tissue of origin. As is the
case with murine studies, there is no standardized definition of
human CLP, and a series of markers have been used to resolve
lymphopoietic progenitors. CD34
+ progenitors with low CD10
most closely resemble the original CLP described by Galy and
colleagues [11]. CD24 was absent from CD34
+ CD10
Lo
progenitors suggesting they are not dedicated to the B lineage [16].
To obtain more detailed information about B lineage
progression, we studied CD22, CD20 and cytoplasmic Igm (cIgm)
expression with each of the three subsets (Figure 3A, B).
Approximately, 20% of CD34
+ CD10
Hi cells expressed CD22,
and 5–10% of them were CD20
+. There were very few cIgm
positive cells among CB and BM CD34
+ fraction (less than 2% of
CD34
+ cells). Zelm et al. reported that incomplete DH-JH
rearrangements were initiated in CD34
+ CD22
+CD19
2 cells,
and VH-DJH rearrangements mainly occurred in CD34
2 CD10
+
CD19
+ CD20
2 cells [27]. IgK/IgL gene rearrangements were
initiated after CD34 down-regulation and expression of cIgm (in
CD34
2 CD10
+ CD19
+ CD20
2 cells). Therefore, we analyzed
immunoglobulin DH-JH gene rearrangements by quantitative PCR
in subsets separated on the basis of CD10. The human IgH locus
contains 66 rearrangeable VH,2 7D H, and 6 JH genes, so we
designed probes to detect the predominant DH3–10 gene segment
and the JH4 gene segment. This particular DH-JH rearrangement
most frequently occurs in humans [28]. Contrary to our
expectations, Ig gene rearrangement was a late event, with high
levels found only in the CD34
+ CD10
Hi subset. Similar results
were obtained in three independent experiments using cord blood
or adult marrow derived progenitors.
Hematopoietic cells in humans and mice differ with respect to
many cell surface markers [1–7,11–16,27,29], complicating
extrapolation between the two (Figure S2). For example, freshly
isolated murine lymphoid progenitors do not express CD10 [10].
In contrast, we now show that levels parallel lineage progression in
humans. Our results suggest that CD10 levels represent an
important variable, increasing coincident with initiation of Ig gene
rearrangement and before uniform expression of either CD20 or
CD22. Subsequent experiments were aimed at determining if it
corresponded to differentiation and lineage restriction.
CD10 density increases with expression of lymphoid
lineage transcription factors, but loss of myeloid
potential by CD10 bearing progenitors is a late event
Consistent with changes in proteins detected by flow cytometry,
transcripts for the RAG-1recombinase enzyme markedly increased
Figure 1. Densities of CD10 vary among human CD34
+ cells
isolated in different ways. CD34
+ cells enriched from CB, G-CSF
mobilized peripheral blood (G-PB) and BM were stained with PE-CD10
and APC-CD34 for flow cytometry analysis. (A) They were partitioned
into three categories according to CD10 levels. (B) Incidences of CD34
+
CD10
2,C D 3 4
+ CD10
Lo, and CD34
+ CD10
Hi progenitors in these
preparations are shown. Similar results were obtained in three
independent experiments utilizing specimens from four different
donors. Statistical significances were determined by unpaired two-
tailed t test analysis: *, p,0.05 and **, p,0.01.
doi:10.1371/journal.pone.0012954.g001
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transcription factors are essential for B lymphopoiesis, and the
corresponding transcripts increased in parallel with CD10. In
contrast, expression of the myeloid associated myeloperoxidase
(MPO) gene was down-regulated with CD10 acquisition. All of these
three subsets expressed C/Ebpa and Notch1. Results were very
similar when CB rather than BM was used as a source of progenitors
(data not shown). Hystad and colleagues performed microarray
analyses on human B lineage progenitors separated according to
presence or absence of markers [29]. Comparing their developmen-
tal milestones to our RT-PCR results indicates that CD34
+ CD10
Lo
cells are relatively primitive, but primed for lymphopoiesis. Abrupt
increases in CD10 transcripts were found in another study to
correspond with Ig gene rearrangement activity [27].
Interestingly, the experiments described above revealed that
CD34
+ progenitors with CD10 still had C/Ebpa gene expression,
and CD34
+ CD10
Lo progenitors expressed MPO at a low level, as
reported before [27,29]. This raises important questions concerning
their differentiation potential. Therefore, we sorted CD34
+ cells
from CB and carefully assessed their progeny over four weeks of
culture (Figure 5A, B). A substantial wave of CD33
+ myeloid cells
was observed in cultures initiated with CD34
+ CD10
Lo progenitors,
Figure 3. DH-JH rearrangements\cur in progenitors with high CD10 densities. (A) Expression patterns of CD22 and CD20 on CD34
+ CD10
2,
CD34
+ CD10
Lo, and CD34
+ CD10
Hi progenitors derived from CB and BM were analyzed using flow cytometry. (B) After staining CD34
+ or CD34
2cells
from CB and BM with CD10 and CD34 antibodies and fixing, they were stained with cytoplasmic Igm. The data is representative of results obtained
with cells from at least three diffferent donors in three separate experiments. (C) The indicated fractions were sorted from CB, and genomic DNA was
extracted from 10
4 cells. Sorted CD34
+ CD38
2 and CD34
2 CD10
+ CD19
+ cells were used as negative and positive controls, respectively. C/Ebpa
specific PCR reactions were used to determine input quantities. The results are normalized as percentages of peak values for each of the genes and
are representative of that obtained in three independent experiments, using either CB or BM. N.D.; not detected.
doi:10.1371/journal.pone.0012954.g003
Figure 2. High levels of CD10 correspond to progression in the B lineage. (A, B) CD34
+ cells from CB and BM were stained with CD10 and
CD34 as well as the indicated antibodies, and analyzed by flow cytometry. The CD34
+ cells were gated according to CD10 levels and percentages of
cells positive for each marker are shown. Similar results were obtained with cells from at least three different donors in three separate experiments.
doi:10.1371/journal.pone.0012954.g002
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2
stem/progenitors. Human mesenchymal stromal cells were used for
these experiments because of their ability to simultaneously support
B, dendritic and myeloid differentiation. Therefore, we recovered
CD14
2 CD19
2 CD11c
+ CD123
Lo/- conventionaldendritic cells, as
well as CD14
2 CD19
2 CD11c
2 CD123
Hi plasmacytoid dendritic
cells from 2 week co-cultures (Figure 5C, D). We conclude that
CD10
Lo progenitors are not lymphoid lineage restricted.
CD34
+ CD10
Hi progenitors are strictly lineage-committed,
but have diminished ability to expand in culture
Given that CD10
Hi progenitors express characteristics associated
with B lineage lymphocytes, we assumed that they would be potent
progenitors when placed in culture. However, yields of total cells
and CD19
+ B lineage lymphocytes were very low at all time points
in cultures initiated with CD34
+ CD10
Hi progenitors (Figure 5, 6A).
This is despite the fact that these culture conditions are optimized
for human B lymphopoiesis [30] and gave good yields with CD10
2
and CD10
Lo subsets (Figure 5, 6A). Late stages of murine B
lymphopoiesis are most efficiently supported by stromal cell-free
conditions [31], and we recently adapted that approach for human
progenitors [32]. However, attempts to propagate them in four-
week stromal cell-free cultures were unsuccessful (Figure 6B).
In one-week stromal cell-free cultures, CD34
+ CD10
Hi
progenitors gave rise to CD34
2 CD33
2 CD19
+ lymphocytes,
but only with poor survival and/or minimal expansion (Figure
6C). In contrast to CD34
+ CD10
2 and CD34
+ CD10
Lo
progenitors, the CD10
Hi subset proliferated poorly during four
days of culture and incorporated little BrdU (Figure 6D). This
contrasts with a report that some CD34
+CD19
+ cells could
generate myeloid and erythroid lineage cells [33]. Although
CD10
Hi progenitors are rare in CB, we were able to determine
that they also expanded poorly in these cultures.
It is possible that CD34
+ CD10
Hi progenitors are post-mitotic in
vivo, but staining of freshly isolated BM with the Ki67 proliferation
marker revealed that all three subsets include dividing cells (Figure
7A, B). The restricted and rapid generation of CD34
2 CD19
+
lymphocytes by CD34
+ CD10
Hi progenitors suggests they
represent a lineage committed stage. They could have recently
exited cell cycle in vivo. Alternatively, conditions required for their
expansion in culture remain undefined.
Definition of factors that regulate human B lymphopoiesis
remains an elusive goal, and no cytokine that supports robust
human B lymphopoiesis has been found. B lymphopoiesis is not
impaired in SCID patients with mutations in the common c chain
required for IL-7 responses, and there is no clear requirement for
this cytokine in cultures of freshly isolated progenitors
[19,30,32,34–36]. On the other hand, there is some evidence that
stromal cells and pre-cultured hematopoietic cells can recognize
IL-7 [37–40]. In addition, a very transient response of human fetal
B progenitor cells was reported [19,41,42].
To conclude, the composition of umbilical cord blood, G-CSF
mobilized peripheral blood and adult bone marrow is markedly
different with respect to lymphopoietic cell subsets. Our results
show that CD10 density increases in parallel with expression of B
lymphoid lineage genes and surface markers on CD34
+ progen-
itors. This parameter also corresponds to loss of potential to
generate myeloid and dendritic cells in culture. Complete
restriction to a B lineage fate appears to be a late event.
Materials and Methods
Origin and isolation of cells
CB cells were collected from healthy, full-term neonates
immediately after Caesarean section or normal delivery. BM
and G-CSF mobilized PB cells were collected from normal healthy
donors. All samples were collected after written informed consent,
using protocols approved by the Investigational Review Boards at
Osaka University and Oklahoma Medical Research Foundation.
Mononuclear cells were separated by Ficoll-Paque PLUS (GE
Healthcare Bio-Science AB, Uppsala, Sweden) or Lymphocyte
Separation Medium (Mediatech, Inc., Manassas, VA) and
centrifugation. Purification of CB and BM CD34
+ cells was
performed using Direct human CD34 Progenitor Cell Isolation
Kit (Miltenyi Biotec, Auburn, CA). Human specimens were
separately analyzed with respect to progenitor phenotypes to
reveal individual to individual variability. Rare progenitor cells
were mixed to have sufficient numbers to initiate culture
experiments. Human mesenchymal stem cells were purchased
from Lonza (Walkersville, MD), and maintained in Mesenchymal
Stem Cell Growth Medium (MSCGM, Lonza). Flow cytometric
analysis confirmed that the cultured hMSC expressed CD105,
CD166, CD29, and CD44, but not CD14, CD34, or CD45.
Co-cultures for human B lymphocytes
Co-cultures of CD34
+ cells on hMSC were performed as
previously described [30]. hMSC were seeded in 12-well tissue
plates 1 or 2 days before setting up the co-cultures. Isolated CD34
+
cells (2610
3 cells/well) were plated on sub-confluent hMSC layers
in MSCGM in the presence of 10 ng/ml SCF and 5 ng/ml FL.
Recombinant human SCF and FL proteins were purchased from
R&D Systems, Inc. (Minneapolis, MN). Half of the culture
medium was replaced with fresh medium containing the same
cytokines twice a week.
Stromal cell-free cultures for human B lymphocytes
Stromal cell-free cultures were performed as previously described
[32]. The cultures were usually maintained in QBSFH60 (Quality
Biological, Inc., Gaithersburg, MD) containing10% FCS, 100 U/ml
penicillin, and 100 mg/ml streptomycin with indicated cytokines.
Figure 4. Gene expression patterns suggest that lymphoid
commitment parallels acquisition of CD10. CD34
+ CD10
2, CD34
+
CD10
Lo and CD34
+ CD10
Hi cells were sorted from BM. mRNA was
extracted from each subset, and quantitative RT-PCR was conducted.
The results are normalized as percentages of peak values for each of the
genes and are representative of three independent experiments. Similar
results were obtained in three experiments, using either CB or BM.
doi:10.1371/journal.pone.0012954.g004
hCD10 Density on B Progenitors
PLoS ONE | www.plosone.org 5 September 2010 | Volume 5 | Issue 9 | e12954Recombinant human IL-7 and G-CSF proteins were purchased
from R&D Systems. Half of the culture medium was replaced with
fresh medium containing the same cytokines once a week. The
cytokines wereused at the following concentrations: SCF, 10 ng/ml;
FL, 5 ng/ml; G-CSF, 10 ng/ml; and IL-7, 5 ng/ml.
Flow cytometry and cell sorting
Flow cytometric analysis was performed with a FACS Calibur
or FACS LSRII (BD Biosciences Immunocytometry Systems, San
Jose, CA) using standard multicolor immunofluorescent staining
protocols. Mouse monoclonal Abs against the following human
cell surface molecules were purchased: phycoerythrin (PE)-CD7,
FITC-CD9, PE-CD10, allophycocyanin (APC)-CD10, APC-
CD11c, FITC-CD14, PE-CD19, FITC-CD20, FITC-CD33,
PE-CD34, APC-CD34, APC-CD90, PE-CD117, PE-CD123,
PE-CD135, FITC-IgM and FITC-Ki67 from BD Bioscieinces/
BD Pharmingen (Franklin Lakes, NJ); APC-CD22 from Bio
Legend (San Diego, CA); phycoerythrin 5-succinimidylester (PC5)-
CD19, PC5-CD24 from Beckman Coulter (Marseilles, France). In
some experiments, CD34
+ CD10
2, CD34
+ CD10
Lo and CD34
+
CD10
Hi cells were sorted using a FACS Aria (BD Biosciences
Immunocytometry Systems) and subjected to the cultures for
human B lymphocytes. In this case, enriched CD34
+ cells were
stained with APC-CD34 and PE-CD10.
Real-time quantitative PCR analysis of IgH gene
rearrangement
A Genomic DNA was isolated from 1610
4 sorted subsets with a
DNeasy Tissue Kit (QIAGEN, Valencia, CA). Taqman-based
quantitative PCR was used to detect IgH gene rearrangement,
using TaqMan Universal PCR Master Mix (Applied Biosystems,
Foster City, CA). The probe was designed to detect one of the
Figure 5. Both CD34
+ CD10
2 and CD34
+ CD10
Lo subsets can generate DC and myeloid lineage cells.( A ,B )C D 3 4
+ CD10
2, CD34
+ CD10
Lo and
CD34
+CD10
HicellsweresortedfromCBandculturedwithhMSCinthepresenceofSCFandFLfor4weeks.Representativeflowcytometryresultsareshown
for a 4 week co-culture experiment performed with pooled cord blood specimens (A). The cultured cells were collected weekly, and numbers of generated
CD33
+ myeloid cells (B, upper panel) and CD10
+ CD19
+ B cells (B, lower panel) were determined. Similar results were obtained in three independent
experiments.(C,D)CD34
+CD10
2and CD34
+CD10
Lo CBcellswereculturedwithhMSCinthepresenceofSCFandFLfor2weeks.Cellsrecoveredandgated
as CD14
2,C D 3 4
2 and CD19
2 were characterized by flow cytometry (C), and numbers used to calculate yields per input cells (D). Similar results were
obtained in three independent experiments. Statistical significances were determined by unpaired two-tailed t test analysis: *, p,0.05 and **, p,0.01.
doi:10.1371/journal.pone.0012954.g005
hCD10 Density on B Progenitors
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where DH-JH rearrangement most frequently occurrs in humans
(Applied Biosystems) [28]. Expression levels were determined by
the internal control gene (C/Ebpa). Each sample was measured
in triplicate, and the comparative threshold cycle method was
used for relative quantification of gene expression. The primer
sequences are available from the authors on request.
RNA isolation and Real-time quantitative PCR analysis of
gene expression
The mRNAs were isolated from sorted cells by using RNeasy
Mini Kit (QIAGEN). The cDNAs were then prepared from
DNase I-treated mRNA by using oligo(dT) and Moloney murine
leukemia virus reverse transcriptase (Invitrogen, Carlsbad, CA).
Reactions were quantified with fluorescent TaqMan technology.
Figure 6. CD34
+ CD10
Hi progenitors can differentiate but not proliferate in vitro. (A) CD34
+ CD10
2, CD34
+ CD10
Lo and CD34
+ CD10
Hi cells
were sorted from CB and stromal cell co-cultures were maintained with SCF and FL for 4 weeks before flow cytometry analyses. (B) The three
categories of CD34
+ CB progenitors were cultured under stromal cell-free conditions, but with SCF, FL and IL-7 for 3 weeks. Numbers of total and
CD10
+ CD19
+ cells per input progenitor were calculated. (C) CD34
+ CD10
Lo and CD34
+ CD10
Hi cells were sorted from BM and cultured under stromal
cell-free conditions for 1 week. The generated cells were stained with CD19, CD33 and CD34 and were analyzed by flow cytometry. One
representative determination is shown. (D) CD34
+ CD10
2, CD34
+ CD10
Lo and CD34
+ CD10
Hi cells were sorted from CB and cultured in the presence of
SCF, FL, and G-CSF for 4 days. They were pulsed with 10 mM BrdU for the final 48 hours. Similar results were obtained in three independent
experiments. Statistical significances were determined by unpaired two-tailed t test analysis: **, p,0.01. N.D.; not detected.
doi:10.1371/journal.pone.0012954.g006
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were used in the ABI750 sequence detection system (Applied
Biosystems). Reactions were run at an annealing temperature of
60uC with 40 cycles. Each sample was measured in triplicate, and
the comparative threshold cycle method was used for relative
quantification of gene expression.
BrdU assay
CD34
+ CD10
2, CD34
+ CD10
Lo and CD34
+ CD10
Hi cells
were sorted and cultured in the presence of 10 ng/ml SCF,
5 ng/ml FL, and 10 ng/ml G-CSF for 4 days. They were
pulsed with 10 mM BrdU for the final 48 hours. FITC BrdU
Flow Kit purchased from BD Bioscieinces/BD Pharmingen was
used.
Statistical analyses
Student’s t-test was performed to assess statistical differences. All
results are shown as mean values 6 SD.
Supporting Information
Figure S1 The efficiency of B cell generation in culture depends
on the source of progenitor cells. CD34
+ cells were sorted from
CB, G-CSF mobilized peripheral blood (G-PB) or BM, and
cultured with hMSC in the presence of SCF and FL for 4 weeks. A
representative analysis is shown (A). Numbers of total and CD10
+
CD19
+ B cells generated were calculated (B). Similar results were
obtained in three independent experiments. Statistical signifi-
cances were determined by unpaired two-tailed t test analysis:
*, p,0.05 and **, p,0.01.
Found at: doi:10.1371/journal.pone.0012954.s001 (0.45 MB TIF)
Figure S2 Comparison of B lymphopoiesis in mice and humans.
Our new results and ones from the literature were used to
construct a possible sequence of events in human B lymphocyte
formation. Progressive down-regulation of c-Kit occurs from
stem/early progenitor stages in mice, and our observations suggest
that is also the case for humans. Three categories of human
CD10
2, CD10
Lo and CD10
Hi cells evaluated in the present study
are positioned with respect to stem cells and lymphoid committed
progenitors.
Found at: doi:10.1371/journal.pone.0012954.s002 (0.25 MB TIF)
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Figure 7. All three subsets include dividing cells when freshly isolated from BM. CD34
+ CD10
2, CD34
+ CD10
Lo and CD34
+ CD10
Hi cells were
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